IL-9 expression by invariant NKT cells is not imprinted during thymic development

Journal of Immunology

Volumn 195, Issue 7, 2015, Pages 3463-3471

  Monteiro, Marta ^a,b   Agua Doce, Ana ^a,b   Almeida, Catarina F ^a,b   Fonseca Pereira, Diogo ^a   Veiga Fernandes, Henrique ^a   Graca, Luis ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 4; INTERLEUKIN 9; NEUROPILIN 1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BATF PROTEIN, MOUSE; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; KLRB1C PROTEIN, MOUSE; LY ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES; FEMALE; GRANULOCYTE; HUMAN; IN VIVO STUDY; INVARIANT NKT CELL; KINETICS; MALE; MAST CELL; MOUSE; MUCOSA INFLAMMATION; NATURAL KILLER CELL; NKT1; NKT17; NKT2; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS; THYMUS DEVELOPMENT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; EMBRYOLOGY; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LUNG; METABOLISM; MONONUCLEAR CELL; NATURAL KILLER T CELL; PATHOLOGY; PNEUMONIA; PYROGLYPHIDAE; SECRETION (PROCESS); TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD4; ANTIGENS, LY; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELLS, CULTURED; GRANULOCYTES; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTORS; INTERLEUKIN-4; INTERLEUKIN-9; LEUKOCYTES, MONONUCLEAR; LUNG; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; NEUROPILIN-1; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; PNEUMONIA; PYROGLYPHIDAE; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 84942446783     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403170     Document Type: Article

References (54)

1. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
2. Olszak, T., J. F. Neves, C. M. Dowds, K. Baker, J. Glickman, N. O. Davidson, C. S. Lin, C. Jobin, S. Brand, K. Sotlar, et al. 2014. Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature 509: 497-502.
3. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188: 1521-1528.
4. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191: 1895-1903.
5. Rossjohn, J., D. G. Pellicci, O. Patel, L. Gapin, and D. I. Godfrey. 2012. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12: 845-857.
6. Gumperz, J. E., S. Miyake, T. Yamamura, and M. B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625-636.
7. Michel, M. L., A. C. Keller, C. Paget, M. Fujio, F. Trottein, P. B. Savage, C. H. Wong, E. Schneider, M. Dy, and M. C. Leite-de-Moraes. 2007. Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204: 995-1001.
8. Coquet, J. M., S. Chakravarti, K. Kyparissoudis, F. W. McNab, L. A. Pitt, B. S. McKenzie, S. P. Berzins, M. J. Smyth, and D. I. Godfrey. 2008. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD42NK1.12 NKT cell population. Proc. Natl. Acad. Sci. USA 105: 11287-11292.
9. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Va14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
10. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al. 2001. The natural killer T-cell ligand a-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7: 1052-1056.
11. Tupin, E., Y. Kinjo, and M. Kronenberg. 2007. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5: 405-417.
12. Olszak, T., D. An, S. Zeissig, M. P. Vera, J. Richter, A. Franke, J. N. Glickman, R. Siebert, R. M. Baron, D. L. Kasper, and R. S. Blumberg. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336: 489-493.
13. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
14. Monteiro, M., and L. Graca. 2014. iNKT cells: innate lymphocytes with a diverse response. Crit. Rev. Immunol. 34: 81-90.
15. Lee, Y. J., K. L. Holzapfel, J. Zhu, S. C. Jameson, and K. A. Hogquist. 2013. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14: 1146-1154.
16. Monteiro, M., C. F. Almeida, M. Caridade, J. C. Ribot, J. Duarte, A. Agua-Doce, I. Wollenberg, B. Silva-Santos, and L. Graca. 2010. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-b. J. Immunol. 185: 2157-2163.
17. Moreira-Teixeira, L., M. Resende, O. Devergne, J. P. Herbeuval, O. Hermine, E. Schneider, M. Dy, A. Cordeiro-da-Silva, and M. C. Leite-de-Moraes. 2012. Rapamycin combined with TGF-b converts human invariant NKT cells into suppressive Foxp3+ regulatory cells. J. Immunol. 188: 624-631.
18. Chang, P. P., P. Barral, J. Fitch, A. Pratama, C. S. Ma, A. Kallies, J. J. Hogan, V. Cerundolo, S. G. Tangye, R. Bittman, et al. 2012. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat. Immunol. 13: 35-43.
19. King, I. L., A. Fortier, M. Tighe, J. Dibble, G. F. Watts, N. Veerapen, A. M. Haberman, G. S. Besra, M. Mohrs, M. B. Brenner, and E. A. Leadbetter. 2012. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat. Immunol. 13: 44-50.
20. Tonti, E., M. Fedeli, A. Napolitano, M. Iannacone, U. H. von Andrian, L. G. Guidotti, S. Abrignani, G. Casorati, and P. Dellabona. 2012. Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4+ T cell help. J. Immunol. 188: 3217-3222.
21. Bai, L., S. Deng, R. Reboulet, R. Mathew, L. Teyton, P. B. Savage, and A. Bendelac. 2013. Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides. Proc. Natl. Acad. Sci. USA 110: 16097-16102.
22. Sag, D., P. Krause, C. C. Hedrick, M. Kronenberg, and G. Wingender. 2014. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Invest. 124: 3725-3740.
23. Yoshimoto, T., B. Min, T. Sugimoto, N. Hayashi, Y. Ishikawa, Y. Sasaki, H. Hata, K. Takeda, K. Okumura, L. Van Kaer, et al. 2003. Nonredundant roles for CD1drestricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J. Exp. Med. 197: 997-1005.
24. Jones, T. G., J. Hallgren, A. Humbles, T. Burwell, F. D. Finkelman, P. Alcaide, K. F. Austen, and M. F. Gurish. 2009. Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J. Immunol. 183: 5251-5260.
25. Kim, H. S., and D. H. Chung. 2013. IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner. Mucosal Immunol. 6: 347-357.
26. Constantinides, M. G., and A. Bendelac. 2013. Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 25: 161-167.
27. Michel, M. L., and M. C. Leite-de-Moraes. 2013. Comment on "Induced IL-17-producing invariant NKT cells require activation in presence of TGF-b and IL-1b". J. Immunol. 190: 5909-5910.
28. Monteiro, M., C. F. Almeida, A. Agua-Doce, and L. Graca. 2013. Induced IL-17-producing invariant NKT cells require activation in presence of TGF-b and IL-1b. J. Immunol. 190: 805-811.
29. Monteiro, M., and L. Graca. 2013. Response to comment on "Induced IL-17-producing invariant NKT cells require activation in presence of TGF-b and IL-1b". J. Immunol. 190: 5910-5911.
30. Veldhoen, M., C. Uyttenhove, J. Van Snick, H. Helmby, A. Westendorf, J. Buer, B. Martin, C. Wilhelm, and B. Stockinger. 2008. Transforming growth factor-b "reprograms" the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9: 1341-1346.
31. Dardalhon, V., A. Awasthi, H. Kwon, G. Galileos, W. Gao, R. A. Sobel, M. Mitsdoerffer, T. B. Strom, W. Elyaman, I. C. Ho, et al. 2008. IL-4 inhibits TGF-b-induced Foxp3+ T cells and, together with TGF-b, generates IL-9+ IL-10+ Foxp32 effector T cells. Nat. Immunol. 9: 1347-1355.
32. McNab, F. W., D. G. Pellicci, K. Field, G. Besra, M. J. Smyth, D. I. Godfrey, and S. P. Berzins. 2007. Peripheral NK1.1 NKT cells are mature and functionally distinct from their thymic counterparts. J. Immunol. 179: 6630-6637.
33. Staudt, V., E. Bothur, M. Klein, K. Lingnau, S. Reuter, N. Grebe, B. Gerlitzki, M. Hoffmann, A. Ulges, C. Taube, et al. 2010. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192-202.
34. Chang, H. C., S. Sehra, R. Goswami, W. Yao, Q. Yu, G. L. Stritesky, R. Jabeen, C. McKinley, A. N. Ahyi, L. Han, et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11: 527-534.
35. Jabeen, R., R. Goswami, O. Awe, A. Kulkarni, E. T. Nguyen, A. Attenasio, D. Walsh, M. R. Olson, M. H. Kim, R. S. Tepper, et al. 2013. Th9 cell development requires a BATF-regulated transcriptional network. J. Clin. Invest. 123: 4641-4653.
36. Lohoff, M., H. W. Mittrücker, S. Prechtl, S. Bischof, F. Sommer, S. Kock, D. A. Ferrick, G. S. Duncan, A. Gessner, and T. W. Mak. 2002. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. USA 99: 11808-11812.
37. Townsend, J. M., G. P. Fallon, J. D. Matthews, P. Smith, E. H. Jolin, and N. A. McKenzie. 2000. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13: 573-583.
38. Louahed, J., Y. Zhou, W. L. Maloy, P. U. Rani, C. Weiss, Y. Tomer, A. Vink, J. Renauld, J. Van Snick, N. C. Nicolaides, et al. 2001. Interleukin 9 promotes influx and local maturation of eosinophils. Blood 97: 1035-1042.
39. Kearley, J., J. S. Erjefalt, C. Andersson, E. Benjamin, C. P. Jones, A. Robichaud, S. Pegorier, Y. Brewah, T. J. Burwell, L. Bjermer, et al. 2011. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am. J. Respir. Crit. Care Med. 183: 865-875.
40. Wilhelm, C., K. Hirota, B. Stieglitz, J. Van Snick, M. Tolaini, K. Lahl, T. Sparwasser, H. Helmby, and B. Stockinger. 2011. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 12: 1071-1077.
41. Michel, M. L., D. Mendes-da-Cruz, A. C. Keller, M. Lochner, E. Schneider, M. Dy, G. Eberl, and M. C. Leite-de-Moraes. 2008. Critical role of ROR-gt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA 105: 19845-19850.
42. Schmitt, E., M. Klein, and T. Bopp. 2014. Th9 cells, new players in adaptive immunity. Trends Immunol. 35: 61-68.
43. Nowak, M., L. Lynch, S. Yue, A. Ohta, M. Sitkovsky, S. P. Balk, and M. A. Exley. 2010. The A2aR adenosine receptor controls cytokine production in iNKT cells. Eur. J. Immunol. 40: 682-687.
44. Oliveira, V. G., M. Caridade, R. S. Paiva, J. Demengeot, and L. Graca. 2011. Sub-optimal CD4+ T-cell activation triggers autonomous TGF-b-dependent conversion to Foxp3+ regulatory T cells. Eur. J. Immunol. 41: 1249-1255.
45. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296: 553-555.
46. Stetson, D. B., M. Mohrs, R. L. Reinhardt, J. L. Baron, Z. E. Wang, L. Gapin, M. Kronenberg, and R. M. Locksley. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198: 1069-1076.
47. Lu, Y., S. Hong, H. Li, J. Park, B. Hong, L. Wang, Y. Zheng, Z. Liu, J. Xu, J. He, et al. 2012. Th9 cells promote antitumor immune responses in vivo. J. Clin. Invest. 122: 4160-4171.
48. Purwar, R., C. Schlapbach, S. Xiao, H. S. Kang, W. Elyaman, X. Jiang, A. M. Jetten, S. J. Khoury, R. C. Fuhlbrigge, V. K. Kuchroo, et al. 2012. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat. Med. 18: 1248-1253.
49. Fujii, S., K. Shimizu, Y. Okamoto, N. Kunii, T. Nakayama, S. Motohashi, and M. Taniguchi. 2013. NKT cells as an ideal anti-tumor immunotherapeutic. Front. Immunol. 4: 409-416.
50. Li, M. O., Y. Y. Wan, S. Sanjabi, A. K. Robertson, and R. A. Flavell. 2006. Transforming growth factor-b regulation of immune responses. Annu. Rev. Immunol. 24: 99-146.
51. Berzins, S. P., and D. S. Ritchie. 2014. Natural killer T cells: drivers or passengers in preventing human disease? Nat. Rev. Immunol. 14: 640-646.
52. Agua-Doce, A., and L. Graca. 2012. Regulatory T cells and the control of the allergic response. J. Allergy (Cairo) 2012: 948901-948910.
53. Yao, W., Y. Zhang, R. Jabeen, E. T. Nguyen, D. S. Wilkes, R. S. Tepper, M. H. Kaplan, and B. Zhou. 2013. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 38: 360-372.
54. Nagata, Y., H. Kamijuku, M. Taniguchi, S. Ziegler, and K. Seino. 2007. Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer T cell function. Int. Arch. Allergy Immunol. 144: 305-314.